Arvinas, Inc. revenue breakdown overview

Arvinas, Inc. revenue for the last year amounted to 263.40 M USD, the most of which — 263.40 M USD — came from its highest performing source at the moment, Protein Degradation Therapies, the year earlier bringing 78.50 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Arvinas, Inc. 263.40 M USD, and the year before that — 78.50 M USD.